MarginsXMarginsX
Home › Markets › Health Care › HAE

Haemonetics Corporation (HAE)

HAE trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$121.34
-1.30% on the day
Market cap
$5.5B
Mid cap
Revenue · 2025
$1.3B
-2.0% on 2024
Net income · 2025
$97.3M
7.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-03-28, https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/0000313143-26-000050-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-28.

Profile

FieldValue
TickerHAE on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year1991
SEC CIK0000313143
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inMA

Financials · 2025

LineValue
Revenue$1.3B
Net income$97.3M
Operating income$156.7M
Net margin7.3%
Operating margin11.7%
Revenue growth-2.0%
Cash$245.4M
Total assets$2.4B
P/E (computed)56.8×
P/S (computed)4.1×

Warning signs

Cash runway
Cash-flow positive
$260.7M cash at September 26, 2026
Share count, 1 year
-2.7%
2025-10-31 to 2026-10-30 · -10.3% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$99K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$260.7M cash; operating cash flow $86.2M a quarter.Report 2026-09-26
Shares outstanding45,537,511 (2026-10-30); 46,809,672 a year earlier; 50,742,477 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-06-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $99K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2027
2026-09-26
$357.8M$46.3M$128.1M$260.7M$1.1B$1.4B10-Q 2026-11-05
Q1 2027
2026-06-27
$339.4M$33.0M$52.3M$223.4M$1.2B$1.4B10-Q 2026-08-06
Q4 2026
2026-03-28
$346.4M-$20.1M$70.9M$245.4M$1.2B$1.3B10-K 2026-05-20
Q3 2026
2025-12-27
$339.0M$44.7M$93.6M$363.4M$1.2B$1.3B10-Q 2026-02-05
Q2 2026
2025-09-27
$327.3M$38.7M$111.3M$296.4M$1.2B$1.3B10-Q 2026-11-05
Q1 2026
2025-06-28
$321.4M$34.0M$17.4M$292.9M$1.2B$1.3B10-Q 2026-08-06
Q4 2025
2025-03-29
$330.6M$58.0M$116.6M$306.8M$1.2B$1.4B10-K 2026-05-20
Q3 2025
2024-12-28
$348.5M$37.5M$43.8M$320.8M$1.2B$1.4B10-Q 2026-02-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2019-07-30
Latest annual report10-K2026-05-20
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-06-09

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.5%
1 month+1.0%
3 months+36.0%
Year to date+53.4%
1 year+66.3%
From 52-week high-3.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
MMEDMiniMed Group Inc.$18.65+3.67%$5.2B
MMSIMerit Medical Systems Inc.$86.35-0.32%$5.2B
TFXTeleflex Incorporated$157.10+1.51%$6.2B
ICUIICU Medical Inc.$181.87+1.45%$4.5B
STVNStevanato Group S.p.A.$15.53-1.71%$4.2B
HTFLHeartflow Inc.$46.86-3.30%$4.1B
NVSTEnvista Holdings Corporation$24.03-1.88%$3.9B
PLSEPulse Biosciences Inc Common Stock (DE)$46.36-8.09%$3.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier